SEC Filing Details

Document Details

Form
Filing Date
Oct 23, 2025
Document Date
Oct 21, 2025
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Neuphoria Therapeutics Inc.
Issuer
NEUPHORIA THERAPEUTICS INC.
Filer
LYNX1 CAPITAL MANAGEMENT LP